Cytokine changes in the pathophysiology of poststroke depression

General Hospital Psychiatry

Volumn 34, Issue 1, 2012, Pages 35-39

  Su, Jian An ^a,b,c   Chou, Shih Yong ^a,b,c   Tsai, Ching Shu ^a,b,c   Hung, Tai Hsin ^a,b,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Cytokines; Immune imbalance; Poststroke depression

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POSTSTROKE DEPRESSION; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN MODIFICATION; TIME SERIES ANALYSIS;

AGED; CYTOKINES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; STROKE; TAIWAN;

EID: 84855341401     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2011.09.020     Document Type: Article

References (39)

1. Whyte E.M., Mulsant B.H. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 2002, 52:253-264.
2. Robinson R.G. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003, 54:376-387.
3. Starkstein S.E., Robinson R.G., Berthier M.L., Parikh R.M., Price T.R. Differential mood changes following basal ganglia vs thalamic lesions. Arch Neurol 1988, 45:725-730.
4. Gainotti G., Azzoni A., Marra C. Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br J Psychiatry 1999, 175:163-167.
5. House A. Depression associated with stroke. J Neuropsychiatry Clin Neurosci 1996, 8:453-457.
6. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:201-217.
7. Dowlati Y., Herrmann N., Swardfager W., et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
8. Maes M. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999, 461:25-46.
9. Dentino A.N., Pieper C.F., Rao M.K., et al. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 1999, 47:6-11.
10. Zorrilla E.P., Luborsky L., McKay J.R., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001, 15:199-226.
11. Penninx B.W., Kritchevsky S.B., Yaffe K., et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003, 54:566-572.
12. Anisman H., Hayley S., Turrin N., Merali Z. Cytokines as a stressor: implications for depressive illness. Int J Neuropsychopharmacol 2002, 5:357-373.
13. Kelley K.W., Bluthe R.M., Dantzer R., et al. Cytokine-induced sickness behavior. Brain Behav Immun 2003, 17(Suppl 1):S112-S118.
14. Kubera M., Kenis G., Bosmans E., Scharpe S., Maes M. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10. Neuropsychopharmacology 2000, 23:89-98.
15. Kubera M., Lin A.H., Kenis G., et al. Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 2001, 21:199-206.
16. Maes M., Song C., Lin A.H., et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 1999, 20:370-379.
17. Kenis G., Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 2002, 5:401-412.
18. Spalletta G., Bossu P., Ciaramella A., et al. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 2006, 11:984-991.
19. Craft T.K., DeVries A.C. Role of IL-1 in poststroke depressive-like behavior in mice. Biol Psychiatry 2006, 60:812-818.
20. Yang L., Zhang Z., Sun D., et al. The serum interleukin-18 is a potential marker for development of post-stroke depression. Neurol Res 2010, 32:340-346.
21. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
22. Kunitz S.C., Gross C.R., Heyman A., et al. The pilot Stroke Data Bank: definition, design, and data. Stroke 1984, 15:740-746.
23. Collin C., Wade D.T., Davies S., Horne V. The Barthel ADL Index: a reliability study. Int Disabil Stud 1988, 10:61-63.
24. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
25. Berg A., Lonnqvist J., Palomaki H., Kaste M. Assessment of depression after stroke: a comparison of different screening instruments. Stroke 2009, 40:523-529.
26. Andersen G., Vestergaard K., Riis J., Lauritzen L. Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale. Acta Psychiatr Scand 1994, 90:190-195.
27. Niedermaier N., Bohrer E., Schulte K., Schlattmann P., Heuser I. Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke. J Clin Psychiatry 2004, 65:1619-1623.
28. Robinson R.G., Jorge R.E., Moser D.J., et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008, 299:2391-2400.
29. Emsley H.C., Smith C.J., Gavin C.M., et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003, 139:93-101.
30. Iadecola C., Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 2001, 14:89-94.
31. Ferrarese C., Longoni M., Stanzani L. Cytokine network in acute stroke. Neurol Sci 2001, 22:287-288.
32. Cowen P.J. Cortisol, serotonin and depression: all stressed out?. Br J Psychiatry 2002, 180:99-100.
33. Young E.A., Haskett R.F., Grunhaus L., et al. Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry 1994, 51:701-707.
34. Meyer J.H., Ginovart N., Boovariwala A., et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 2006, 63:1209-1216.
35. Connor T.J., Starr N., O'Sullivan J.B., Harkin A. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?. Neurosci Lett 2008, 441:29-34.
36. Tu H., Rady P.L., Juelich T., et al. Cytokine regulation of tryptophan metabolism in the hypothalamic-pituitary-adrenal (HPA) axis: implications for protective and toxic consequences in neuroendocrine regulation. Cell Mol Neurobiol 2005, 25:673-680.
37. Dantzer R., Wollman E., Vitkovic L., Yirmiya R. Cytokines and depression: fortuitous or causative association?. Mol Psychiatry 1999, 4:328-332.
38. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995, 332:1351-1362.
39. McCann S.M., Lyson K., Karanth S., et al. Mechanism of action of cytokines to induce the pattern of pituitary hormone secretion in infection. Ann N Y Acad Sci 1995, 771:386-395.